SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-097763
Filing Date
2024-04-16
Accepted
2024-04-16 16:15:57
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A d599560ddefa14a.htm DEFA14A 27636
2 GRAPHIC g599560dso157.jpg GRAPHIC 44467
3 GRAPHIC g599560dsp157a.jpg GRAPHIC 40711
4 GRAPHIC g599560dsp158.jpg GRAPHIC 928
  Complete submission text file 0001193125-24-097763.txt   147716
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38266 | Film No.: 24848016
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)